GlassScriptPhysician profile
Olivia Ayre
NPI 1326497579
$696.57
in general payments reported to CMS, 2019-2025
14 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.48 · 2023: $15.00 · 2024: $144 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $132.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $102.23 | 2024-2025 | Injectafer |
| Lilly USA, LLC | $68.74 | 2024-2025 | Zepbound, Mounjaro |
| Ardelyx, INC. | $57.69 | 2025 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $53.16 | 2021-2025 | Farxiga, Breztri |
| Amgen INC. | $42.34 | 2025 | Repatha |
| Pfizer INC. | $37.84 | 2025 | |
| Novo Nordisk INC | $36.47 | 2025 | Ozempic |
| Baxter Healthcare | $35.09 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.47 | 2023-2025 | Xifaxan, Trulance |
| Medtronic, INC. | $30.55 | 2024 | Intellis Adaptivestim |
| C2n Diagnostics, LLC | $29.29 | 2025 | Precivityad2 |
| Otsuka America Pharmaceutical, INC. | $18.82 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $17.59 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Ayre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.